G Cenacchi1, M Fanin, L B De Giorgi, C Angelini. 1. Clinical Department of Radiological and Histocytopathological Sciences, University of Bologna, 40138 Bologna, Italy.
Abstract
BACKGROUND: The dysferlin gene has recently been shown to be involved in limb girdle muscular dystrophy type 2B and its allelic disease, Miyoshi myopathy, both of which are characterised by an active muscle degeneration and regeneration process. Dysferlin is known to play an essential role in skeletal muscle fibre repair, but the process underlying the pathogenetic mechanism of dysferlinopathy is not completely understood. AIMS: To define both specific alterations of muscle fibres and a possible sequential mechanism of myopathy development. METHODS: A histological, immunohistochemical, and ultrastructural analysis of 10 muscle biopsies from patients with molecularly diagnosed dysferlinopathy. RESULTS: An inflammatory response was seen in most of the muscle biopsies. The immunohistochemical pattern demonstrated active regeneration and inflammation. Non-necrotic fibres showed alterations at different submicroscopic levels, namely: the sarcolemma and basal lamina, subsarcolemmal region, and sarcoplasmic compartment. In the subsarcolemmal region there were prominent aggregations of small vesicles, probably derived from the Golgi apparatus, which consisted of empty, swollen cisternae. In the sarcolemma there were many gaps and microvilli-like projections, whereas the basal lamina was multilayered. CONCLUSIONS: The histopathological, immunohistochemical, and ultrastructural data show that dysferlinopathy is characterised by a very active inflammatory/degenerative process, possibly associated with an inefficient repair and regenerative system. The presence of many crowded vesicles just beneath the sarcolemma provides submicroscopical proof of a defective resealing mechanism, which fails to repair the sarcolemma.
BACKGROUND: The dysferlin gene has recently been shown to be involved in limb girdle muscular dystrophy type 2B and its allelic disease, Miyoshi myopathy, both of which are characterised by an active muscle degeneration and regeneration process. Dysferlin is known to play an essential role in skeletal muscle fibre repair, but the process underlying the pathogenetic mechanism of dysferlinopathy is not completely understood. AIMS: To define both specific alterations of muscle fibres and a possible sequential mechanism of myopathy development. METHODS: A histological, immunohistochemical, and ultrastructural analysis of 10 muscle biopsies from patients with molecularly diagnosed dysferlinopathy. RESULTS: An inflammatory response was seen in most of the muscle biopsies. The immunohistochemical pattern demonstrated active regeneration and inflammation. Non-necrotic fibres showed alterations at different submicroscopic levels, namely: the sarcolemma and basal lamina, subsarcolemmal region, and sarcoplasmic compartment. In the subsarcolemmal region there were prominent aggregations of small vesicles, probably derived from the Golgi apparatus, which consisted of empty, swollen cisternae. In the sarcolemma there were many gaps and microvilli-like projections, whereas the basal lamina was multilayered. CONCLUSIONS: The histopathological, immunohistochemical, and ultrastructural data show that dysferlinopathy is characterised by a very active inflammatory/degenerative process, possibly associated with an inefficient repair and regenerative system. The presence of many crowded vesicles just beneath the sarcolemma provides submicroscopical proof of a defective resealing mechanism, which fails to repair the sarcolemma.
Authors: C Matsuda; Y K Hayashi; M Ogawa; M Aoki; K Murayama; I Nishino; I Nonaka; K Arahata; R H Brown Journal: Hum Mol Genet Date: 2001-08-15 Impact factor: 6.150
Authors: Dimple Bansal; Katsuya Miyake; Steven S Vogel; Séverine Groh; Chien-Chang Chen; Roger Williamson; Paul L McNeil; Kevin P Campbell Journal: Nature Date: 2003-05-08 Impact factor: 49.962
Authors: Mengfatt Ho; Cristina M Post; Leah R Donahue; Hart G W Lidov; Roderick T Bronson; Holly Goolsby; Simon C Watkins; Gregory A Cox; Robert H Brown Journal: Hum Mol Genet Date: 2004-07-14 Impact factor: 6.150
Authors: Carlo Minetti; Massimo Bado; Paolo Broda; Federica Sotgia; Claudio Bruno; Ferruccio Galbiati; Daniela Volonte; Giuseppe Lucania; Antonio Pavan; Eduardo Bonilla; Michael P Lisanti; Giuseppe Cordone Journal: Am J Pathol Date: 2002-01 Impact factor: 4.307
Authors: Stephanie L Sellers; Nadia Milad; Zoe White; Chris Pascoe; Rayleigh Chan; Geoffrey W Payne; Chun Seow; Fabio Rossi; Michael A Seidman; Pascal Bernatchez Journal: J Lipid Res Date: 2017-11-25 Impact factor: 5.922
Authors: Vanessa R Haynes; Stacey N Keenan; Jackie Bayliss; Erin M Lloyd; Peter J Meikle; Miranda D Grounds; Matthew J Watt Journal: J Lipid Res Date: 2019-06-15 Impact factor: 5.922
Authors: Wei-Qing Han; Min Xia; Ming Xu; Krishna M Boini; Joseph K Ritter; Ning-Jun Li; Pin-Lan Li Journal: J Cell Sci Date: 2012-02-20 Impact factor: 5.285
Authors: Alexis R Demonbreun; Avery D Posey; Konstantina Heretis; Kayleigh A Swaggart; Judy U Earley; Peter Pytel; Elizabeth M McNally Journal: FASEB J Date: 2009-12-11 Impact factor: 5.191
Authors: Kanneboyina Nagaraju; Rashmi Rawat; Edina Veszelovszky; Rachana Thapliyal; Akanchha Kesari; Susan Sparks; Nina Raben; Paul Plotz; Eric P Hoffman Journal: Am J Pathol Date: 2008-02-14 Impact factor: 4.307